News NEWS Latest news Firm news, deals, comment and updates – from across our international locations Contact our media team Pause carousel Breadcrumb Home News News and PR ADVANCED SEARCH OC Ventures 10/03/2025 1 min Osborne Clarkes advises Imperial spinout Siftr Bio aiming to improve the precision of ADC cancer therapies International legal practice Osborne Clarke has advised a new Imperial College London spinout, Siftr Bio (Siftr) that aims to improve the performance of an emerging class of cancer treatments known as antibody-drug conjugates (ADCs), on its pre-seed fundraising. ADCs are... Intellectual property 07/03/2025 1 min Victory for Osborne Clarke client Avanci in Court of Appeal today Today, the Court of Appeal dismissed Tesla's appeal against the High Court's finding that Tesla's claim raised no serious issue to be tried. Partner and UK Head IP Disputes Arty Rajendra and Associate Director Luke Maunder worked alongside Avanci and... Energy and energy transition 07/03/2025 1 min Osborne Clarke advises NORD/LB on EUR 86.5 million German BESS financing The energy finance team of Osborne Clarke has advised NORD/LB, one of the global leaders in sustainable project finance, on their first large-scale battery storage (BESS) financing in Germany. The 209MWh Stendal project will be developed by Nofar Energy and... 18/02/2025 1 min Osborne Clarke has been ranked in Chambers & Partners France 2025 Osborne Clarke in France is honored to be recognized for its expertise. Team ranking TMT Corporate / M&A Mid-Market 6 ranked lawyers Thomas Devred | Pharma/Life Sciences: Regulatory François-Régis Fabre-Falret | Real Estate Nassim Ghalimi | Restructuring David Haccoun |... Corporate 06/03/2025 1 min Osborne Clarke advised on the sale of the Caesar Augustus luxury hotel in Capri The Statuto group, owner of some of the most prestigious luxury hotels in Italy and Europe, has acquired the Caesar Augustus hotel in Capri, the only five-star hotel on the island with 56 rooms and suites, from the Signorini family... Corporate 03/02/2025 2 mins 'Mid-tier deals to increase in 2025,' predicts Osborne Clarke's international Corporate Team Strong outlook due to relatively stable economic conditions, supply and demand dynamics and the need for transformation and change Increased transactions expected across high-growth sectors: Technology, Media and Comms (including Artificial Intelligence), Financial Services/FinTech, Renewables and Life Sciences International legal... Life Sciences and Healthcare 24/02/2025 1 min Osborne Clarke advises cancer immunotherapeutics company Epitopea on US$31m pre-Series A financing International legal practice Osborne Clarke has advised Epitopea, a transatlantic cancer immunotherapeutics company developing accessible off-the-shelf RNA-based immunotherapies, on the closing of a US$31 million pre-Series A financing. The financing brings the total capital raised by Epitopea to over US$45... View all
OC Ventures 10/03/2025 1 min Osborne Clarkes advises Imperial spinout Siftr Bio aiming to improve the precision of ADC cancer therapies International legal practice Osborne Clarke has advised a new Imperial College London spinout, Siftr Bio (Siftr) that aims to improve the performance of an emerging class of cancer treatments known as antibody-drug conjugates (ADCs), on its pre-seed fundraising. ADCs are...
Intellectual property 07/03/2025 1 min Victory for Osborne Clarke client Avanci in Court of Appeal today Today, the Court of Appeal dismissed Tesla's appeal against the High Court's finding that Tesla's claim raised no serious issue to be tried. Partner and UK Head IP Disputes Arty Rajendra and Associate Director Luke Maunder worked alongside Avanci and...
Energy and energy transition 07/03/2025 1 min Osborne Clarke advises NORD/LB on EUR 86.5 million German BESS financing The energy finance team of Osborne Clarke has advised NORD/LB, one of the global leaders in sustainable project finance, on their first large-scale battery storage (BESS) financing in Germany. The 209MWh Stendal project will be developed by Nofar Energy and...
18/02/2025 1 min Osborne Clarke has been ranked in Chambers & Partners France 2025 Osborne Clarke in France is honored to be recognized for its expertise. Team ranking TMT Corporate / M&A Mid-Market 6 ranked lawyers Thomas Devred | Pharma/Life Sciences: Regulatory François-Régis Fabre-Falret | Real Estate Nassim Ghalimi | Restructuring David Haccoun |...
Corporate 06/03/2025 1 min Osborne Clarke advised on the sale of the Caesar Augustus luxury hotel in Capri The Statuto group, owner of some of the most prestigious luxury hotels in Italy and Europe, has acquired the Caesar Augustus hotel in Capri, the only five-star hotel on the island with 56 rooms and suites, from the Signorini family...
Corporate 03/02/2025 2 mins 'Mid-tier deals to increase in 2025,' predicts Osborne Clarke's international Corporate Team Strong outlook due to relatively stable economic conditions, supply and demand dynamics and the need for transformation and change Increased transactions expected across high-growth sectors: Technology, Media and Comms (including Artificial Intelligence), Financial Services/FinTech, Renewables and Life Sciences International legal...
Life Sciences and Healthcare 24/02/2025 1 min Osborne Clarke advises cancer immunotherapeutics company Epitopea on US$31m pre-Series A financing International legal practice Osborne Clarke has advised Epitopea, a transatlantic cancer immunotherapeutics company developing accessible off-the-shelf RNA-based immunotherapies, on the closing of a US$31 million pre-Series A financing. The financing brings the total capital raised by Epitopea to over US$45...